SEC 13F Intelligence

Managers / Q3 2021 · view latest →

Duquesne Family Office LLC

CIK 0001536411 · Part of the Duquesne family · 40 WEST 57TH STREET, 25TH FLOOR, NEW YORK, NY, 10019 · (212) 830-6500

Reported Value
$3.1B
Q3 2021
Positions
49
Filings on Record
32
2019–present window
Filed
Nov 15, 2021
original filing

Summary

Duquesne Family Office LLC reported $3.1B in U.S.-listed holdings across 49 positions for Q3 2021.

Its largest position, CPNG, represents 14.0% of the portfolio.

Compared with Q2 2021, the fund opened 13 new positions and exited 16.

Portfolio Metrics

Turnover
+12.7%
vs prior filed quarter
Top-10 Concentration
+72.3%
share of reported value
Largest Position
+14.0%
Coupang
New / Exited
13 / 16
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.7BQ4 ’18Q1 ’19: $3.4BQ2 ’19: $3.4BQ3 ’19: $2.6BQ4 ’19: $3.4BQ4 ’19Q1 ’20: $2.5BQ2 ’20: $3.3BQ3 ’20: $3.4BQ4 ’20: $3.7BQ4 ’20Q1 ’21: $4.5BQ2 ’21: $4.0BQ3 ’21: $3.1BQ4 ’21: $2.8BQ4 ’21Q1 ’22: $2.3BQ2 ’22: $1.4BQ3 ’22: $1.8BQ4 ’22: $2.0BQ4 ’22Q1 ’23: $2.3BQ2 ’23: $2.9BQ3 ’23: $2.8BQ4 ’23: $3.4BQ4 ’23Q1 ’24: $4.4BQ2 ’24: $2.9BQ3 ’24: $3.0BQ4 ’24: $3.7BQ4 ’24Q1 ’25: $3.1BQ2 ’25: $4.1BQ3 ’25: $4.1BQ4 ’25: $4.5BQ4 ’25Q1 ’26: $3.4Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 97.4%Other: 0.9%ADR: 0.9%Tracking Stk: 0.8%
  • Common Stock · 97.4% · $3.0B
  • Other · 0.9% · $28M
  • ADR · 0.9% · $28M
  • Tracking Stk · 0.8% · $25M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
LYVLive Nation Entertainment InNEW+427.8K427.8K+$39M$39M
ZMZoom Video Communications InNEW+117.7K117.7K+$31M$31M
PRCTProcept Biorobotics CorpNEW+600.0K600.0K+$23M$23M
STNEStoneco LtdNEW+382.1K382.1K+$13M$13M
ABCLAbcellera Biologics IncNEW+659.8K659.8K+$13M$13M
FSLYFastly IncNEW+257.7K257.7K+$10M$10M
LADLithia Mtrs IncNEW+29.1K29.1K+$9M$9M
LVSLas Vegas Sands CorpNEW+230.0K230.0K+$8M$8M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2021

48 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CPNGCoupang Inchistory →CL A14.02%$432M15.51M
2AMZNAmazon Com Inchistory →COM10.41%$321M97.6K
3GOOGLAlphabet Inchistory →CAP STK CL A10.16%$313M117.0K
4SBUXStarbucks Corphistory →COM7.55%$232M2.11M
5MSFTMicrosoft Corphistory →COM7.12%$219M777.7K
6PANWPalo Alto Networks Inchistory →COM6.21%$191M399.0K
7FCXFreeport-Mcmoran Inchistory →CL B5.11%$157M4.84M
8EXPEExpedia Group Inchistory →COM NEW4.87%$150M914.3K
9TMUST-Mobile Us Inchistory →COM3.55%$109M855.2K
10BKNGBooking Holdings Inchistory →COM3.35%$103M43.5K
11ABNBAirbnb Inchistory →COM CL A2.73%$84M501.4K
12Reata Pharmaceuticals IncCL A2.27%$70M695.0K
13INTUIntuithistory →COM1.53%$47M87.1K
14CVNACarvana Cohistory →CL A1.34%$41M137.2K
15PLTRPalantir Technologies Inchistory →CL A1.27%$39M1.63M
16LYVLive Nation Entertainment Inhistory →COM1.27%$39M427.8K
17METAFacebook Inchistory →CL A1.17%$36M105.9K
18KBRKbr Inchistory →COM1.11%$34M865.6K
19MRNAModerna Inchistory →COM1.07%$33M86.0K
20ZMZoom Video Communications Inhistory →CL A1.00%$31M117.7K
21PENNPenn Natl Gaming Inchistory →COM0.98%$30M417.2K
22Coupa Software IncCOM0.98%$30M137.6K
23SESea Ltdhistory →SPONSORD ADS0.91%$28M87.9K
24Flex LtdORD0.88%$27M1.53M
25TECKTeck Resources Ltdhistory →CL B0.84%$26M1.04M
26OPCHOption Care Health Inchistory →COM NEW0.81%$25M1.03M
27Liberty Media Corp DelCOM SER C FRMLA0.81%$25M485.8K
28DISHDish Network Corporationhistory →CL A0.78%$24M550.9K
29FTCHQFarfetch Ltdhistory →ORD SH CL A0.77%$24M629.5K
30PRCTProcept Biorobotics Corphistory →COM0.74%$23M600.0K
31Nektar TherapeuticsCOM0.58%$18M1.00M
32OSCROscar Health Inchistory →CL A0.56%$17M994.3K
33STNEStoneco Ltdhistory →COM CL A0.43%$13M382.1K
34ABCLAbcellera Biologics Inchistory →COM0.43%$13M659.8K
35FSLYFastly Inchistory →CL A0.34%$10M257.7K
36LADLithia Mtrs Inchistory →COM0.30%$9M29.1K
37Confluent IncCLASS A COM0.27%$8M140.3K
38CRBUCaribou Biosciences Inchistory →COM0.21%$6M271.4K
39RXRXRecursion Pharmaceuticals Inhistory →CL A0.19%$6M259.9K
40OMFOnemain Hldgs Inchistory →COM0.15%$5M83.8K
41Smartsheet IncCOM CL A0.14%$4M64.7K
42BBBYOverstock Com Inc Delhistory →COM0.13%$4M49.6K
43SSentinelone Inchistory →CL A0.10%$3M60.0K
44CCCCcc Intelligent Solutions Hlhistory →COM0.10%$3M281.9K
45CFCf Inds Hldgs Inchistory →COM0.09%$3M47.0K
46ACADAcadia Pharmaceuticals Inchistory →COM0.04%$1M74.4K
47Sensei Biotherapeutics IncCOM0.03%$1M100.0K
48Decarbonization Plus Acqu IiCLASS A COM0.03%$954,00094.9K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$3.4B70May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$4.5B62Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$4.1B65Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$4.1B69Aug 15, 202513F-HRchanges · EDGAR ↗
Q1 2025$3.1B52May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$3.7B78Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$3.0B75Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$2.9B64Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$4.4B73May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$3.4B51Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$2.8B41Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$2.9B53Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$2.3B48May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$2.0B58Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.8B65Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$2.3B51May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$2.8B49Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$3.1B49Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021REVEALED$4.0B52Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021REVEALED$4.5B64May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$3.7B56Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$3.4B61Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$3.3B72Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$2.5B46May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$3.4B62Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$2.6B43Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$3.4B61Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$3.4B61May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.7B31Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.